ImportRefusal LogoImportRefusal

Laboratorios Grossman, S.A.

⚠️ High Risk

FEI: 3006330902 • Ciudad De Mexico, Ciudad de Mexico • MEXICO

FEI

FEI Number

3006330902

📍

Location

Ciudad De Mexico, Ciudad de Mexico

🇲🇽

Country

MEXICO
🏢

Address

Avenida Calzada De Tlalpan No. 2021, Col. Parque San Andres, Coyoacan, Ciudad De Mexico, Ciudad de Mexico, Mexico

High Risk

FDA Import Risk Assessment

67.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

31
Total Refusals
6
Unique Violations
10/27/2025
Latest Refusal
3/26/2003
Earliest Refusal

Score Breakdown

Violation Severity
76.3×40%
Refusal Volume
55.8×30%
Recency
95.9×20%
Frequency
13.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7528×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1186×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

273×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

3242×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
10/27/2025
56JCL31CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/1/2025
60LCQ08BENZYDAMINE HCL (ANALGESIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/2/2025
66JAA02LIOTHYRONINE SODIUM (THYROID HORMONE)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2023
62GDL95LOTEPREDNOL ETABONATE (ANTI-INFLAMMATORY)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/10/2023
65CDA99NUTRIENT/TONIC N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/7/2022
65QCY60CYCLOBENZAPRINE HYDROCHLORIDE (RELAXANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/17/2022
54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/12/2022
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/6/2022
54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/23/2022
64LCY67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/1/2022
60BDA20METHIONINE (ACIDIFIER)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2021
61CCK99ANTI-ANEMIC, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/30/2021
54ADB99VITAMIN, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/25/2021
54ADY05VITAMIN B12 (CYANOCOBALAMIN)
324NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/20/2021
61VDB01SIMETHICONE (ANTI-FLATULENT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/1/2020
66PDY18ZINC OXIDE (ULTRAVIOLET SCREEN/SUNSCREEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/10/2020
66GCL25DIMETHICONE 350 (SURGICAL/PROSTHETIC AID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/27/2020
61GCY81MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/24/2020
65CAK07LEVOCARNITINE (NUTRIENT/TONIC)
3280FRNMFGREG
Division of Southeast Imports (DSEI)
6/28/2019
61CCK99ANTI-ANEMIC, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/19/2019
61VAY01SIMETHICONE (ANTI-FLATULENT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/17/2019
54YBL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/7/2019
63VCY02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/18/2017
63VCY02HYDROQUINONE (DEPIGMENTOR)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/24/2016
56YCB99ANTIBIOTIC N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/1/2016
65NCY16CYANOCOBALAMIN CO 57 (RADIOACTIVE AGENT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/24/2010
54CCR02L-ARGININE (PROTEIN)
27DRUG GMPS
472NO ENGLISH
75UNAPPROVED
Cincinnati District Office (CIN-DO)
5/23/2007
54AGK05VITAMIN B12 (CYANOCOBALAMIN)
27DRUG GMPS
75UNAPPROVED
Cincinnati District Office (CIN-DO)
5/22/2007
65CNK07LEVOCARNITINE (NUTRIENT/TONIC)
27DRUG GMPS
Cincinnati District Office (CIN-DO)
5/28/2003
65CCP07LEVOCARNITINE (NUTRIENT/TONIC)
118NOT LISTED
472NO ENGLISH
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/26/2003
54AFK02VITAMIN B1 (THIAMINE)
324NO ENGLISH
Chicago District Office (CHI-DO)

Frequently Asked Questions

What is Laboratorios Grossman, S.A.'s FDA import refusal history?

Laboratorios Grossman, S.A. (FEI: 3006330902) has 31 FDA import refusal record(s) in our database, spanning from 3/26/2003 to 10/27/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Grossman, S.A.'s FEI number is 3006330902.

What types of violations has Laboratorios Grossman, S.A. received?

Laboratorios Grossman, S.A. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios Grossman, S.A. come from?

All FDA import refusal data for Laboratorios Grossman, S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.